Global Sample Preparation in Genomics, Proteomics, and Epigenomics Supply, Demand and Key Producers, 2026-2032
The global Sample Preparation in Genomics, Proteomics, and Epigenomics market size is expected to reach $ 276 million by 2032, rising at a market growth of 5.7% CAGR during the forecast period (2026-2032).
Sample preparation in Genomics, Proteomics, and Epigenomics refers to a series of operations that isolate and transform target molecules from raw samples such as tissues or cells to adapt them for downstream high-throughput detection. In genomics, the core of preparation lies in obtaining high-purity, intact DNA through lysis and purification, and then fragmenting it to construct sequencing libraries. Preparation in proteomics is more complex, requiring quantification and enzymatic digestion of proteins after extraction to break them down into peptides, and often necessitating the removal of high-abundance interfering proteins to ensure the sensitivity of mass spectrometry detection. Epigenomics preparation, in addition to these steps, requires the preservation of epigenetic modification information, such as cross-linking chromatin to study protein-DNA interactions, or using bisulfite treatment to convert unmethylated cytosine, thereby locating methylation sites during sequencing. Furthermore, in epigenetic studies involving RNA, degradation must be strictly prevented. The preparation processes for all three require precise optimization based on the specific molecular targets and analytical platforms.
The global market for Sample Preparation in Genomics, Proteomics, and Epigenomics exhibits a pattern of both technological leadership and regional specialization. North America, leveraging its leading instrument companies and large-scale automated platforms, dominates the development of standardized preparation technologies for high-throughput, low-loss samples, maintaining a leading position, particularly in single-cell and micro-sample preparation. Europe, drawing on its deep foundation in structural biology and proteomics, focuses on handling challenging samples, such as membrane protein extraction and post-translational modification enrichment, emphasizing precision and reproducibility. The Asia-Pacific region, with China at its core, is driven by substantial research demand, rapidly emerging in the manufacturing of magnetic bead purification reagents and automated liquid handling workstations, providing cost-effective solutions and gradually moving from import substitution to technology export.
This report studies the global Sample Preparation in Genomics, Proteomics, and Epigenomics demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Sample Preparation in Genomics, Proteomics, and Epigenomics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Sample Preparation in Genomics, Proteomics, and Epigenomics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Sample Preparation in Genomics, Proteomics, and Epigenomics total market, 2021-2032, (USD Million)
Global Sample Preparation in Genomics, Proteomics, and Epigenomics total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Sample Preparation in Genomics, Proteomics, and Epigenomics total market, key domestic companies, and share, (USD Million)
Global Sample Preparation in Genomics, Proteomics, and Epigenomics revenue by player, revenue and market share 2021-2026, (USD Million)
Global Sample Preparation in Genomics, Proteomics, and Epigenomics total market by Type, CAGR, 2021-2032, (USD Million)
Global Sample Preparation in Genomics, Proteomics, and Epigenomics total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Sample Preparation in Genomics, Proteomics, and Epigenomics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include QIAGEN GmbH, Bio-Rad Laboratories, Inc., Danaher Corporation, Merck KGaA, PerkinElmer, Inc., BGI, Cytiva, Illumina, Roche Sequencing Solutions, New England Biolabs, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Sample Preparation in Genomics, Proteomics, and Epigenomics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market, By Region:
1. How big is the global Sample Preparation in Genomics, Proteomics, and Epigenomics market?
2. What is the demand of the global Sample Preparation in Genomics, Proteomics, and Epigenomics market?
3. What is the year over year growth of the global Sample Preparation in Genomics, Proteomics, and Epigenomics market?
4. What is the total value of the global Sample Preparation in Genomics, Proteomics, and Epigenomics market?
5. Who are the Major Players in the global Sample Preparation in Genomics, Proteomics, and Epigenomics market?
6. What are the growth factors driving the market demand?
Sample preparation in Genomics, Proteomics, and Epigenomics refers to a series of operations that isolate and transform target molecules from raw samples such as tissues or cells to adapt them for downstream high-throughput detection. In genomics, the core of preparation lies in obtaining high-purity, intact DNA through lysis and purification, and then fragmenting it to construct sequencing libraries. Preparation in proteomics is more complex, requiring quantification and enzymatic digestion of proteins after extraction to break them down into peptides, and often necessitating the removal of high-abundance interfering proteins to ensure the sensitivity of mass spectrometry detection. Epigenomics preparation, in addition to these steps, requires the preservation of epigenetic modification information, such as cross-linking chromatin to study protein-DNA interactions, or using bisulfite treatment to convert unmethylated cytosine, thereby locating methylation sites during sequencing. Furthermore, in epigenetic studies involving RNA, degradation must be strictly prevented. The preparation processes for all three require precise optimization based on the specific molecular targets and analytical platforms.
The global market for Sample Preparation in Genomics, Proteomics, and Epigenomics exhibits a pattern of both technological leadership and regional specialization. North America, leveraging its leading instrument companies and large-scale automated platforms, dominates the development of standardized preparation technologies for high-throughput, low-loss samples, maintaining a leading position, particularly in single-cell and micro-sample preparation. Europe, drawing on its deep foundation in structural biology and proteomics, focuses on handling challenging samples, such as membrane protein extraction and post-translational modification enrichment, emphasizing precision and reproducibility. The Asia-Pacific region, with China at its core, is driven by substantial research demand, rapidly emerging in the manufacturing of magnetic bead purification reagents and automated liquid handling workstations, providing cost-effective solutions and gradually moving from import substitution to technology export.
This report studies the global Sample Preparation in Genomics, Proteomics, and Epigenomics demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Sample Preparation in Genomics, Proteomics, and Epigenomics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Sample Preparation in Genomics, Proteomics, and Epigenomics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Sample Preparation in Genomics, Proteomics, and Epigenomics total market, 2021-2032, (USD Million)
Global Sample Preparation in Genomics, Proteomics, and Epigenomics total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Sample Preparation in Genomics, Proteomics, and Epigenomics total market, key domestic companies, and share, (USD Million)
Global Sample Preparation in Genomics, Proteomics, and Epigenomics revenue by player, revenue and market share 2021-2026, (USD Million)
Global Sample Preparation in Genomics, Proteomics, and Epigenomics total market by Type, CAGR, 2021-2032, (USD Million)
Global Sample Preparation in Genomics, Proteomics, and Epigenomics total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Sample Preparation in Genomics, Proteomics, and Epigenomics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include QIAGEN GmbH, Bio-Rad Laboratories, Inc., Danaher Corporation, Merck KGaA, PerkinElmer, Inc., BGI, Cytiva, Illumina, Roche Sequencing Solutions, New England Biolabs, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Sample Preparation in Genomics, Proteomics, and Epigenomics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- DNA Sample Preparation
- RNA Sample Preparation
- Protein Sample Preparation
- Epigenetic Modification Targeted Preparation
- Others
- Sequencing Platform Pretreatment
- Mass Spectrometry Platform Pretreatment
- Microarray Hybridization Pretreatment
- PCR Platform Pretreatment
- Others
- All Components Preparation
- Subcellular Components Preparation
- Modified and Enriched Components Preparation
- Others
- Academic Institutes, and Government Institutes
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Others
- QIAGEN GmbH
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Merck KGaA
- PerkinElmer, Inc.
- BGI
- Cytiva
- Illumina
- Roche Sequencing Solutions
- New England Biolabs
- Thermo Fisher Scientific
- Miltenyi Biotec
- Twist Bioscience
1. How big is the global Sample Preparation in Genomics, Proteomics, and Epigenomics market?
2. What is the demand of the global Sample Preparation in Genomics, Proteomics, and Epigenomics market?
3. What is the year over year growth of the global Sample Preparation in Genomics, Proteomics, and Epigenomics market?
4. What is the total value of the global Sample Preparation in Genomics, Proteomics, and Epigenomics market?
5. Who are the Major Players in the global Sample Preparation in Genomics, Proteomics, and Epigenomics market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Sample Preparation in Genomics, Proteomics, and Epigenomics Introduction
1.2 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Sample Preparation in Genomics, Proteomics, and Epigenomics Total Market by Region (by Headquarter Location)
1.3.1 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2032)
1.3.3 China Based Company Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2032)
1.3.4 Europe Based Company Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2032)
1.3.5 Japan Based Company Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2032)
1.3.6 South Korea Based Company Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2032)
1.3.7 ASEAN Based Company Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2032)
1.3.8 India Based Company Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Sample Preparation in Genomics, Proteomics, and Epigenomics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032)
2.2 World Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value by Region
2.2.1 World Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value by Region (2021-2026)
2.2.2 World Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value Forecast by Region (2027-2032)
2.3 United States Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032)
2.4 China Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032)
2.5 Europe Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032)
2.6 Japan Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032)
2.7 South Korea Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032)
2.8 ASEAN Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032)
2.9 India Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032)
3 WORLD SAMPLE PREPARATION IN GENOMICS, PROTEOMICS, AND EPIGENOMICS COMPANIES COMPETITIVE ANALYSIS
3.1 World Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Sample Preparation in Genomics, Proteomics, and Epigenomics in 2025
3.2.3 Global Concentration Ratios (CR8) for Sample Preparation in Genomics, Proteomics, and Epigenomics in 2025
3.3 Sample Preparation in Genomics, Proteomics, and Epigenomics Company Evaluation Quadrant
3.4 Sample Preparation in Genomics, Proteomics, and Epigenomics Market: Overall Company Footprint Analysis
3.4.1 Sample Preparation in Genomics, Proteomics, and Epigenomics Market: Region Footprint
3.4.2 Sample Preparation in Genomics, Proteomics, and Epigenomics Market: Company Product Type Footprint
3.4.3 Sample Preparation in Genomics, Proteomics, and Epigenomics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value Comparison
4.2.1 United States VS China: Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Sample Preparation in Genomics, Proteomics, and Epigenomics Companies and Market Share, 2021-2026
4.3.1 United States Based Sample Preparation in Genomics, Proteomics, and Epigenomics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, (2021-2026)
4.4 China Based Companies Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue and Market Share, 2021-2026
4.4.1 China Based Sample Preparation in Genomics, Proteomics, and Epigenomics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, (2021-2026)
4.5 Rest of World Based Sample Preparation in Genomics, Proteomics, and Epigenomics Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Sample Preparation in Genomics, Proteomics, and Epigenomics Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 DNA Sample Preparation
5.2.2 RNA Sample Preparation
5.2.3 Protein Sample Preparation
5.2.4 Epigenetic Modification Targeted Preparation
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Type (2021-2026)
5.3.2 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Type (2027-2032)
5.3.3 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TECHNOLOGY PLATFORM
6.1 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Overview by Technology Platform: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Technology Platform
6.2.1 Sequencing Platform Pretreatment
6.2.2 Mass Spectrometry Platform Pretreatment
6.2.3 Microarray Hybridization Pretreatment
6.2.4 PCR Platform Pretreatment
6.2.5 Others
6.3 Market Segment by Technology Platform
6.3.1 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Technology Platform (2021-2026)
6.3.2 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Technology Platform (2027-2032)
6.3.3 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Market Share by Technology Platform (2027-2032)
7 MARKET ANALYSIS BY COMPLEXITY
7.1 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Overview by Complexity: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Complexity
7.2.1 All Components Preparation
7.2.2 Subcellular Components Preparation
7.2.3 Modified and Enriched Components Preparation
7.2.4 Others
7.3 Market Segment by Complexity
7.3.1 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Complexity (2021-2026)
7.3.2 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Complexity (2027-2032)
7.3.3 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Market Share by Complexity (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Academic Institutes, and Government Institutes
8.2.2 Hospitals and Clinics
8.2.3 Pharmaceutical and Biotechnology Companies
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Application (2021-2026)
8.3.2 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Application (2027-2032)
8.3.3 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 QIAGEN GmbH
9.1.1 QIAGEN GmbH Details
9.1.2 QIAGEN GmbH Major Business
9.1.3 QIAGEN GmbH Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
9.1.4 QIAGEN GmbH Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 QIAGEN GmbH Recent Developments/Updates
9.1.6 QIAGEN GmbH Competitive Strengths & Weaknesses
9.2 Bio-Rad Laboratories, Inc.
9.2.1 Bio-Rad Laboratories, Inc. Details
9.2.2 Bio-Rad Laboratories, Inc. Major Business
9.2.3 Bio-Rad Laboratories, Inc. Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
9.2.4 Bio-Rad Laboratories, Inc. Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Bio-Rad Laboratories, Inc. Recent Developments/Updates
9.2.6 Bio-Rad Laboratories, Inc. Competitive Strengths & Weaknesses
9.3 Danaher Corporation
9.3.1 Danaher Corporation Details
9.3.2 Danaher Corporation Major Business
9.3.3 Danaher Corporation Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
9.3.4 Danaher Corporation Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Danaher Corporation Recent Developments/Updates
9.3.6 Danaher Corporation Competitive Strengths & Weaknesses
9.4 Merck KGaA
9.4.1 Merck KGaA Details
9.4.2 Merck KGaA Major Business
9.4.3 Merck KGaA Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
9.4.4 Merck KGaA Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Merck KGaA Recent Developments/Updates
9.4.6 Merck KGaA Competitive Strengths & Weaknesses
9.5 PerkinElmer, Inc.
9.5.1 PerkinElmer, Inc. Details
9.5.2 PerkinElmer, Inc. Major Business
9.5.3 PerkinElmer, Inc. Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
9.5.4 PerkinElmer, Inc. Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 PerkinElmer, Inc. Recent Developments/Updates
9.5.6 PerkinElmer, Inc. Competitive Strengths & Weaknesses
9.6 BGI
9.6.1 BGI Details
9.6.2 BGI Major Business
9.6.3 BGI Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
9.6.4 BGI Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 BGI Recent Developments/Updates
9.6.6 BGI Competitive Strengths & Weaknesses
9.7 Cytiva
9.7.1 Cytiva Details
9.7.2 Cytiva Major Business
9.7.3 Cytiva Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
9.7.4 Cytiva Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Cytiva Recent Developments/Updates
9.7.6 Cytiva Competitive Strengths & Weaknesses
9.8 Illumina
9.8.1 Illumina Details
9.8.2 Illumina Major Business
9.8.3 Illumina Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
9.8.4 Illumina Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Illumina Recent Developments/Updates
9.8.6 Illumina Competitive Strengths & Weaknesses
9.9 Roche Sequencing Solutions
9.9.1 Roche Sequencing Solutions Details
9.9.2 Roche Sequencing Solutions Major Business
9.9.3 Roche Sequencing Solutions Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
9.9.4 Roche Sequencing Solutions Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Roche Sequencing Solutions Recent Developments/Updates
9.9.6 Roche Sequencing Solutions Competitive Strengths & Weaknesses
9.10 New England Biolabs
9.10.1 New England Biolabs Details
9.10.2 New England Biolabs Major Business
9.10.3 New England Biolabs Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
9.10.4 New England Biolabs Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 New England Biolabs Recent Developments/Updates
9.10.6 New England Biolabs Competitive Strengths & Weaknesses
9.11 Thermo Fisher Scientific
9.11.1 Thermo Fisher Scientific Details
9.11.2 Thermo Fisher Scientific Major Business
9.11.3 Thermo Fisher Scientific Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
9.11.4 Thermo Fisher Scientific Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Thermo Fisher Scientific Recent Developments/Updates
9.11.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.12 Miltenyi Biotec
9.12.1 Miltenyi Biotec Details
9.12.2 Miltenyi Biotec Major Business
9.12.3 Miltenyi Biotec Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
9.12.4 Miltenyi Biotec Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Miltenyi Biotec Recent Developments/Updates
9.12.6 Miltenyi Biotec Competitive Strengths & Weaknesses
9.13 Twist Bioscience
9.13.1 Twist Bioscience Details
9.13.2 Twist Bioscience Major Business
9.13.3 Twist Bioscience Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
9.13.4 Twist Bioscience Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Twist Bioscience Recent Developments/Updates
9.13.6 Twist Bioscience Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Sample Preparation in Genomics, Proteomics, and Epigenomics Industry Chain
10.2 Sample Preparation in Genomics, Proteomics, and Epigenomics Upstream Analysis
10.3 Sample Preparation in Genomics, Proteomics, and Epigenomics Midstream Analysis
10.4 Sample Preparation in Genomics, Proteomics, and Epigenomics Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Sample Preparation in Genomics, Proteomics, and Epigenomics Introduction
1.2 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Sample Preparation in Genomics, Proteomics, and Epigenomics Total Market by Region (by Headquarter Location)
1.3.1 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2032)
1.3.3 China Based Company Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2032)
1.3.4 Europe Based Company Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2032)
1.3.5 Japan Based Company Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2032)
1.3.6 South Korea Based Company Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2032)
1.3.7 ASEAN Based Company Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2032)
1.3.8 India Based Company Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Sample Preparation in Genomics, Proteomics, and Epigenomics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032)
2.2 World Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value by Region
2.2.1 World Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value by Region (2021-2026)
2.2.2 World Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value Forecast by Region (2027-2032)
2.3 United States Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032)
2.4 China Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032)
2.5 Europe Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032)
2.6 Japan Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032)
2.7 South Korea Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032)
2.8 ASEAN Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032)
2.9 India Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032)
3 WORLD SAMPLE PREPARATION IN GENOMICS, PROTEOMICS, AND EPIGENOMICS COMPANIES COMPETITIVE ANALYSIS
3.1 World Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Sample Preparation in Genomics, Proteomics, and Epigenomics in 2025
3.2.3 Global Concentration Ratios (CR8) for Sample Preparation in Genomics, Proteomics, and Epigenomics in 2025
3.3 Sample Preparation in Genomics, Proteomics, and Epigenomics Company Evaluation Quadrant
3.4 Sample Preparation in Genomics, Proteomics, and Epigenomics Market: Overall Company Footprint Analysis
3.4.1 Sample Preparation in Genomics, Proteomics, and Epigenomics Market: Region Footprint
3.4.2 Sample Preparation in Genomics, Proteomics, and Epigenomics Market: Company Product Type Footprint
3.4.3 Sample Preparation in Genomics, Proteomics, and Epigenomics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value Comparison
4.2.1 United States VS China: Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Sample Preparation in Genomics, Proteomics, and Epigenomics Companies and Market Share, 2021-2026
4.3.1 United States Based Sample Preparation in Genomics, Proteomics, and Epigenomics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, (2021-2026)
4.4 China Based Companies Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue and Market Share, 2021-2026
4.4.1 China Based Sample Preparation in Genomics, Proteomics, and Epigenomics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, (2021-2026)
4.5 Rest of World Based Sample Preparation in Genomics, Proteomics, and Epigenomics Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Sample Preparation in Genomics, Proteomics, and Epigenomics Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 DNA Sample Preparation
5.2.2 RNA Sample Preparation
5.2.3 Protein Sample Preparation
5.2.4 Epigenetic Modification Targeted Preparation
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Type (2021-2026)
5.3.2 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Type (2027-2032)
5.3.3 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TECHNOLOGY PLATFORM
6.1 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Overview by Technology Platform: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Technology Platform
6.2.1 Sequencing Platform Pretreatment
6.2.2 Mass Spectrometry Platform Pretreatment
6.2.3 Microarray Hybridization Pretreatment
6.2.4 PCR Platform Pretreatment
6.2.5 Others
6.3 Market Segment by Technology Platform
6.3.1 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Technology Platform (2021-2026)
6.3.2 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Technology Platform (2027-2032)
6.3.3 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Market Share by Technology Platform (2027-2032)
7 MARKET ANALYSIS BY COMPLEXITY
7.1 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Overview by Complexity: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Complexity
7.2.1 All Components Preparation
7.2.2 Subcellular Components Preparation
7.2.3 Modified and Enriched Components Preparation
7.2.4 Others
7.3 Market Segment by Complexity
7.3.1 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Complexity (2021-2026)
7.3.2 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Complexity (2027-2032)
7.3.3 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Market Share by Complexity (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Academic Institutes, and Government Institutes
8.2.2 Hospitals and Clinics
8.2.3 Pharmaceutical and Biotechnology Companies
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Application (2021-2026)
8.3.2 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Application (2027-2032)
8.3.3 World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 QIAGEN GmbH
9.1.1 QIAGEN GmbH Details
9.1.2 QIAGEN GmbH Major Business
9.1.3 QIAGEN GmbH Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
9.1.4 QIAGEN GmbH Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 QIAGEN GmbH Recent Developments/Updates
9.1.6 QIAGEN GmbH Competitive Strengths & Weaknesses
9.2 Bio-Rad Laboratories, Inc.
9.2.1 Bio-Rad Laboratories, Inc. Details
9.2.2 Bio-Rad Laboratories, Inc. Major Business
9.2.3 Bio-Rad Laboratories, Inc. Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
9.2.4 Bio-Rad Laboratories, Inc. Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Bio-Rad Laboratories, Inc. Recent Developments/Updates
9.2.6 Bio-Rad Laboratories, Inc. Competitive Strengths & Weaknesses
9.3 Danaher Corporation
9.3.1 Danaher Corporation Details
9.3.2 Danaher Corporation Major Business
9.3.3 Danaher Corporation Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
9.3.4 Danaher Corporation Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Danaher Corporation Recent Developments/Updates
9.3.6 Danaher Corporation Competitive Strengths & Weaknesses
9.4 Merck KGaA
9.4.1 Merck KGaA Details
9.4.2 Merck KGaA Major Business
9.4.3 Merck KGaA Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
9.4.4 Merck KGaA Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Merck KGaA Recent Developments/Updates
9.4.6 Merck KGaA Competitive Strengths & Weaknesses
9.5 PerkinElmer, Inc.
9.5.1 PerkinElmer, Inc. Details
9.5.2 PerkinElmer, Inc. Major Business
9.5.3 PerkinElmer, Inc. Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
9.5.4 PerkinElmer, Inc. Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 PerkinElmer, Inc. Recent Developments/Updates
9.5.6 PerkinElmer, Inc. Competitive Strengths & Weaknesses
9.6 BGI
9.6.1 BGI Details
9.6.2 BGI Major Business
9.6.3 BGI Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
9.6.4 BGI Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 BGI Recent Developments/Updates
9.6.6 BGI Competitive Strengths & Weaknesses
9.7 Cytiva
9.7.1 Cytiva Details
9.7.2 Cytiva Major Business
9.7.3 Cytiva Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
9.7.4 Cytiva Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Cytiva Recent Developments/Updates
9.7.6 Cytiva Competitive Strengths & Weaknesses
9.8 Illumina
9.8.1 Illumina Details
9.8.2 Illumina Major Business
9.8.3 Illumina Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
9.8.4 Illumina Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Illumina Recent Developments/Updates
9.8.6 Illumina Competitive Strengths & Weaknesses
9.9 Roche Sequencing Solutions
9.9.1 Roche Sequencing Solutions Details
9.9.2 Roche Sequencing Solutions Major Business
9.9.3 Roche Sequencing Solutions Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
9.9.4 Roche Sequencing Solutions Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Roche Sequencing Solutions Recent Developments/Updates
9.9.6 Roche Sequencing Solutions Competitive Strengths & Weaknesses
9.10 New England Biolabs
9.10.1 New England Biolabs Details
9.10.2 New England Biolabs Major Business
9.10.3 New England Biolabs Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
9.10.4 New England Biolabs Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 New England Biolabs Recent Developments/Updates
9.10.6 New England Biolabs Competitive Strengths & Weaknesses
9.11 Thermo Fisher Scientific
9.11.1 Thermo Fisher Scientific Details
9.11.2 Thermo Fisher Scientific Major Business
9.11.3 Thermo Fisher Scientific Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
9.11.4 Thermo Fisher Scientific Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Thermo Fisher Scientific Recent Developments/Updates
9.11.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.12 Miltenyi Biotec
9.12.1 Miltenyi Biotec Details
9.12.2 Miltenyi Biotec Major Business
9.12.3 Miltenyi Biotec Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
9.12.4 Miltenyi Biotec Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Miltenyi Biotec Recent Developments/Updates
9.12.6 Miltenyi Biotec Competitive Strengths & Weaknesses
9.13 Twist Bioscience
9.13.1 Twist Bioscience Details
9.13.2 Twist Bioscience Major Business
9.13.3 Twist Bioscience Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
9.13.4 Twist Bioscience Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Twist Bioscience Recent Developments/Updates
9.13.6 Twist Bioscience Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Sample Preparation in Genomics, Proteomics, and Epigenomics Industry Chain
10.2 Sample Preparation in Genomics, Proteomics, and Epigenomics Upstream Analysis
10.3 Sample Preparation in Genomics, Proteomics, and Epigenomics Midstream Analysis
10.4 Sample Preparation in Genomics, Proteomics, and Epigenomics Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Sample Preparation in Genomics, Proteomics, and Epigenomics Players in 2025
Table 12. World Sample Preparation in Genomics, Proteomics, and Epigenomics Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Company Evaluation Quadrant
Table 14. Head Office of Key Sample Preparation in Genomics, Proteomics, and Epigenomics Players
Table 15. Sample Preparation in Genomics, Proteomics, and Epigenomics Market: Company Product Type Footprint
Table 16. Sample Preparation in Genomics, Proteomics, and Epigenomics Market: Company Product Application Footprint
Table 17. Sample Preparation in Genomics, Proteomics, and Epigenomics Mergers & Acquisitions Activity
Table 18. United States VS China Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Sample Preparation in Genomics, Proteomics, and Epigenomics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue Market Share (2021-2026)
Table 23. China Based Sample Preparation in Genomics, Proteomics, and Epigenomics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue Market Share (2021-2026)
Table 26. Rest of World Based Sample Preparation in Genomics, Proteomics, and Epigenomics Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue Market Share (2021-2026)
Table 29. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Type (2027-2032) & (USD Million)
Table 32. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Technology Platform, (USD Million), 2021 & 2025 & 2032
Table 33. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Value by Technology Platform (2021-2026) & (USD Million)
Table 34. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Technology Platform (2027-2032) & (USD Million)
Table 35. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Complexity, (USD Million), 2021 & 2025 & 2032
Table 36. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Value by Complexity (2021-2026) & (USD Million)
Table 37. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Complexity (2027-2032) & (USD Million)
Table 38. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Application (2021-2026) & (USD Million)
Table 40. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Application (2027-2032) & (USD Million)
Table 41. QIAGEN GmbH Basic Information, Manufacturing Base and Competitors
Table 42. QIAGEN GmbH Major Business
Table 43. QIAGEN GmbH Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
Table 44. QIAGEN GmbH Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. QIAGEN GmbH Recent Developments/Updates
Table 46. QIAGEN GmbH Competitive Strengths & Weaknesses
Table 47. Bio-Rad Laboratories, Inc. Basic Information, Manufacturing Base and Competitors
Table 48. Bio-Rad Laboratories, Inc. Major Business
Table 49. Bio-Rad Laboratories, Inc. Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
Table 50. Bio-Rad Laboratories, Inc. Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Bio-Rad Laboratories, Inc. Recent Developments/Updates
Table 52. Bio-Rad Laboratories, Inc. Competitive Strengths & Weaknesses
Table 53. Danaher Corporation Basic Information, Manufacturing Base and Competitors
Table 54. Danaher Corporation Major Business
Table 55. Danaher Corporation Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
Table 56. Danaher Corporation Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Danaher Corporation Recent Developments/Updates
Table 58. Danaher Corporation Competitive Strengths & Weaknesses
Table 59. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 60. Merck KGaA Major Business
Table 61. Merck KGaA Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
Table 62. Merck KGaA Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Merck KGaA Recent Developments/Updates
Table 64. Merck KGaA Competitive Strengths & Weaknesses
Table 65. PerkinElmer, Inc. Basic Information, Manufacturing Base and Competitors
Table 66. PerkinElmer, Inc. Major Business
Table 67. PerkinElmer, Inc. Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
Table 68. PerkinElmer, Inc. Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. PerkinElmer, Inc. Recent Developments/Updates
Table 70. PerkinElmer, Inc. Competitive Strengths & Weaknesses
Table 71. BGI Basic Information, Manufacturing Base and Competitors
Table 72. BGI Major Business
Table 73. BGI Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
Table 74. BGI Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. BGI Recent Developments/Updates
Table 76. BGI Competitive Strengths & Weaknesses
Table 77. Cytiva Basic Information, Manufacturing Base and Competitors
Table 78. Cytiva Major Business
Table 79. Cytiva Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
Table 80. Cytiva Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Cytiva Recent Developments/Updates
Table 82. Cytiva Competitive Strengths & Weaknesses
Table 83. Illumina Basic Information, Manufacturing Base and Competitors
Table 84. Illumina Major Business
Table 85. Illumina Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
Table 86. Illumina Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Illumina Recent Developments/Updates
Table 88. Illumina Competitive Strengths & Weaknesses
Table 89. Roche Sequencing Solutions Basic Information, Manufacturing Base and Competitors
Table 90. Roche Sequencing Solutions Major Business
Table 91. Roche Sequencing Solutions Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
Table 92. Roche Sequencing Solutions Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Roche Sequencing Solutions Recent Developments/Updates
Table 94. Roche Sequencing Solutions Competitive Strengths & Weaknesses
Table 95. New England Biolabs Basic Information, Manufacturing Base and Competitors
Table 96. New England Biolabs Major Business
Table 97. New England Biolabs Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
Table 98. New England Biolabs Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. New England Biolabs Recent Developments/Updates
Table 100. New England Biolabs Competitive Strengths & Weaknesses
Table 101. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 102. Thermo Fisher Scientific Major Business
Table 103. Thermo Fisher Scientific Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
Table 104. Thermo Fisher Scientific Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Thermo Fisher Scientific Recent Developments/Updates
Table 106. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 107. Miltenyi Biotec Basic Information, Manufacturing Base and Competitors
Table 108. Miltenyi Biotec Major Business
Table 109. Miltenyi Biotec Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
Table 110. Miltenyi Biotec Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Miltenyi Biotec Recent Developments/Updates
Table 112. Miltenyi Biotec Competitive Strengths & Weaknesses
Table 113. Twist Bioscience Basic Information, Manufacturing Base and Competitors
Table 114. Twist Bioscience Major Business
Table 115. Twist Bioscience Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
Table 116. Twist Bioscience Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Twist Bioscience Recent Developments/Updates
Table 118. Twist Bioscience Competitive Strengths & Weaknesses
Table 119. Global Key Players of Sample Preparation in Genomics, Proteomics, and Epigenomics Upstream (Raw Materials)
Table 120. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Typical Customers
Table 1. World Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Sample Preparation in Genomics, Proteomics, and Epigenomics Players in 2025
Table 12. World Sample Preparation in Genomics, Proteomics, and Epigenomics Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Company Evaluation Quadrant
Table 14. Head Office of Key Sample Preparation in Genomics, Proteomics, and Epigenomics Players
Table 15. Sample Preparation in Genomics, Proteomics, and Epigenomics Market: Company Product Type Footprint
Table 16. Sample Preparation in Genomics, Proteomics, and Epigenomics Market: Company Product Application Footprint
Table 17. Sample Preparation in Genomics, Proteomics, and Epigenomics Mergers & Acquisitions Activity
Table 18. United States VS China Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Sample Preparation in Genomics, Proteomics, and Epigenomics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue Market Share (2021-2026)
Table 23. China Based Sample Preparation in Genomics, Proteomics, and Epigenomics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue Market Share (2021-2026)
Table 26. Rest of World Based Sample Preparation in Genomics, Proteomics, and Epigenomics Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue Market Share (2021-2026)
Table 29. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Type (2027-2032) & (USD Million)
Table 32. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Technology Platform, (USD Million), 2021 & 2025 & 2032
Table 33. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Value by Technology Platform (2021-2026) & (USD Million)
Table 34. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Technology Platform (2027-2032) & (USD Million)
Table 35. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Complexity, (USD Million), 2021 & 2025 & 2032
Table 36. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Value by Complexity (2021-2026) & (USD Million)
Table 37. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Complexity (2027-2032) & (USD Million)
Table 38. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Application (2021-2026) & (USD Million)
Table 40. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Application (2027-2032) & (USD Million)
Table 41. QIAGEN GmbH Basic Information, Manufacturing Base and Competitors
Table 42. QIAGEN GmbH Major Business
Table 43. QIAGEN GmbH Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
Table 44. QIAGEN GmbH Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. QIAGEN GmbH Recent Developments/Updates
Table 46. QIAGEN GmbH Competitive Strengths & Weaknesses
Table 47. Bio-Rad Laboratories, Inc. Basic Information, Manufacturing Base and Competitors
Table 48. Bio-Rad Laboratories, Inc. Major Business
Table 49. Bio-Rad Laboratories, Inc. Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
Table 50. Bio-Rad Laboratories, Inc. Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Bio-Rad Laboratories, Inc. Recent Developments/Updates
Table 52. Bio-Rad Laboratories, Inc. Competitive Strengths & Weaknesses
Table 53. Danaher Corporation Basic Information, Manufacturing Base and Competitors
Table 54. Danaher Corporation Major Business
Table 55. Danaher Corporation Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
Table 56. Danaher Corporation Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Danaher Corporation Recent Developments/Updates
Table 58. Danaher Corporation Competitive Strengths & Weaknesses
Table 59. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 60. Merck KGaA Major Business
Table 61. Merck KGaA Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
Table 62. Merck KGaA Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Merck KGaA Recent Developments/Updates
Table 64. Merck KGaA Competitive Strengths & Weaknesses
Table 65. PerkinElmer, Inc. Basic Information, Manufacturing Base and Competitors
Table 66. PerkinElmer, Inc. Major Business
Table 67. PerkinElmer, Inc. Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
Table 68. PerkinElmer, Inc. Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. PerkinElmer, Inc. Recent Developments/Updates
Table 70. PerkinElmer, Inc. Competitive Strengths & Weaknesses
Table 71. BGI Basic Information, Manufacturing Base and Competitors
Table 72. BGI Major Business
Table 73. BGI Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
Table 74. BGI Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. BGI Recent Developments/Updates
Table 76. BGI Competitive Strengths & Weaknesses
Table 77. Cytiva Basic Information, Manufacturing Base and Competitors
Table 78. Cytiva Major Business
Table 79. Cytiva Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
Table 80. Cytiva Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Cytiva Recent Developments/Updates
Table 82. Cytiva Competitive Strengths & Weaknesses
Table 83. Illumina Basic Information, Manufacturing Base and Competitors
Table 84. Illumina Major Business
Table 85. Illumina Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
Table 86. Illumina Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Illumina Recent Developments/Updates
Table 88. Illumina Competitive Strengths & Weaknesses
Table 89. Roche Sequencing Solutions Basic Information, Manufacturing Base and Competitors
Table 90. Roche Sequencing Solutions Major Business
Table 91. Roche Sequencing Solutions Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
Table 92. Roche Sequencing Solutions Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Roche Sequencing Solutions Recent Developments/Updates
Table 94. Roche Sequencing Solutions Competitive Strengths & Weaknesses
Table 95. New England Biolabs Basic Information, Manufacturing Base and Competitors
Table 96. New England Biolabs Major Business
Table 97. New England Biolabs Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
Table 98. New England Biolabs Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. New England Biolabs Recent Developments/Updates
Table 100. New England Biolabs Competitive Strengths & Weaknesses
Table 101. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 102. Thermo Fisher Scientific Major Business
Table 103. Thermo Fisher Scientific Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
Table 104. Thermo Fisher Scientific Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Thermo Fisher Scientific Recent Developments/Updates
Table 106. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 107. Miltenyi Biotec Basic Information, Manufacturing Base and Competitors
Table 108. Miltenyi Biotec Major Business
Table 109. Miltenyi Biotec Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
Table 110. Miltenyi Biotec Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Miltenyi Biotec Recent Developments/Updates
Table 112. Miltenyi Biotec Competitive Strengths & Weaknesses
Table 113. Twist Bioscience Basic Information, Manufacturing Base and Competitors
Table 114. Twist Bioscience Major Business
Table 115. Twist Bioscience Sample Preparation in Genomics, Proteomics, and Epigenomics Product and Services
Table 116. Twist Bioscience Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Twist Bioscience Recent Developments/Updates
Table 118. Twist Bioscience Competitive Strengths & Weaknesses
Table 119. Global Key Players of Sample Preparation in Genomics, Proteomics, and Epigenomics Upstream (Raw Materials)
Table 120. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Typical Customers
LIST OF FIGURES
Figure 1. Sample Preparation in Genomics, Proteomics, and Epigenomics Picture
Figure 2. World Sample Preparation in Genomics, Proteomics, and Epigenomics Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Sample Preparation in Genomics, Proteomics, and Epigenomics Total Revenue (2021-2032) & (USD Million)
Figure 4. World Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2032) & (USD Million)
Figure 13. Sample Preparation in Genomics, Proteomics, and Epigenomics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032) & (USD Million)
Figure 16. World Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032) & (USD Million)
Figure 18. China Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032) & (USD Million)
Figure 23. India Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Sample Preparation in Genomics, Proteomics, and Epigenomics by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Sample Preparation in Genomics, Proteomics, and Epigenomics Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Sample Preparation in Genomics, Proteomics, and Epigenomics Markets in 2025
Figure 27. United States VS China: Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Market Share by Type in 2025
Figure 31. DNA Sample Preparation
Figure 32. RNA Sample Preparation
Figure 33. Protein Sample Preparation
Figure 34. Epigenetic Modification Targeted Preparation
Figure 35. Others
Figure 36. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Market Share by Type (2021-2032)
Figure 37. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Technology Platform, (USD Million), 2021 & 2025 & 2032
Figure 38. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Market Share by Technology Platform in 2025
Figure 39. Sequencing Platform Pretreatment
Figure 40. Mass Spectrometry Platform Pretreatment
Figure 41. Microarray Hybridization Pretreatment
Figure 42. PCR Platform Pretreatment
Figure 43. Others
Figure 44. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Market Share by Technology Platform (2021-2032)
Figure 45. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Complexity, (USD Million), 2021 & 2025 & 2032
Figure 46. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Market Share by Complexity in 2025
Figure 47. All Components Preparation
Figure 48. Subcellular Components Preparation
Figure 49. Modified and Enriched Components Preparation
Figure 50. Others
Figure 51. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Market Share by Complexity (2021-2032)
Figure 52. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 53. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Market Share by Application in 2025
Figure 54. Academic Institutes, and Government Institutes
Figure 55. Hospitals and Clinics
Figure 56. Pharmaceutical and Biotechnology Companies
Figure 57. Others
Figure 58. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Market Share by Application (2021-2032)
Figure 59. Sample Preparation in Genomics, Proteomics, and Epigenomics Industrial Chain
Figure 60. Methodology
Figure 61. Research Process and Data Source
Figure 1. Sample Preparation in Genomics, Proteomics, and Epigenomics Picture
Figure 2. World Sample Preparation in Genomics, Proteomics, and Epigenomics Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Sample Preparation in Genomics, Proteomics, and Epigenomics Total Revenue (2021-2032) & (USD Million)
Figure 4. World Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (2021-2032) & (USD Million)
Figure 13. Sample Preparation in Genomics, Proteomics, and Epigenomics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032) & (USD Million)
Figure 16. World Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032) & (USD Million)
Figure 18. China Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032) & (USD Million)
Figure 23. India Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Sample Preparation in Genomics, Proteomics, and Epigenomics by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Sample Preparation in Genomics, Proteomics, and Epigenomics Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Sample Preparation in Genomics, Proteomics, and Epigenomics Markets in 2025
Figure 27. United States VS China: Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Sample Preparation in Genomics, Proteomics, and Epigenomics Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Market Share by Type in 2025
Figure 31. DNA Sample Preparation
Figure 32. RNA Sample Preparation
Figure 33. Protein Sample Preparation
Figure 34. Epigenetic Modification Targeted Preparation
Figure 35. Others
Figure 36. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Market Share by Type (2021-2032)
Figure 37. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Technology Platform, (USD Million), 2021 & 2025 & 2032
Figure 38. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Market Share by Technology Platform in 2025
Figure 39. Sequencing Platform Pretreatment
Figure 40. Mass Spectrometry Platform Pretreatment
Figure 41. Microarray Hybridization Pretreatment
Figure 42. PCR Platform Pretreatment
Figure 43. Others
Figure 44. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Market Share by Technology Platform (2021-2032)
Figure 45. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Complexity, (USD Million), 2021 & 2025 & 2032
Figure 46. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Market Share by Complexity in 2025
Figure 47. All Components Preparation
Figure 48. Subcellular Components Preparation
Figure 49. Modified and Enriched Components Preparation
Figure 50. Others
Figure 51. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Market Share by Complexity (2021-2032)
Figure 52. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 53. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Market Share by Application in 2025
Figure 54. Academic Institutes, and Government Institutes
Figure 55. Hospitals and Clinics
Figure 56. Pharmaceutical and Biotechnology Companies
Figure 57. Others
Figure 58. World Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Market Share by Application (2021-2032)
Figure 59. Sample Preparation in Genomics, Proteomics, and Epigenomics Industrial Chain
Figure 60. Methodology
Figure 61. Research Process and Data Source
